CGEM vs SO · $830.3M cap vs P/E 22, rev $29.55B
Cullinan Oncology LLC (CGEM) versus Southern Company (SO) — a side-by-side from cached financials, not a winner call.
Cullinan Oncology LLC (CGEM) is a biotechnology company listed on US.
Southern Company (SO) is a utilities - regulated electric company listed on US.
Latest reported CGEM revenue for 2022-12-31 was $0. Net income was $109.2M. CGEM currently screens at market cap $830.3M.
Latest reported SO revenue for 2025-12-31 was $29.55B. Net income was $4.34B. Revenue was up 10.6% from 2024-12-31 to 2025-12-31. SO currently screens at market cap $101.55B and trailing P/E 22.1.
CGEM currently screens at market cap $830.3M. SO currently screens at market cap $101.55B and trailing P/E 22.1.
Not investment advice. Open the CGEM and SO stock pages for the full models.
Not investment advice.